Expert consensus statement on management of older adults with type 2 diabetes (T2D)

ADA/EASD guidelines suggest that in older adults with diabetes, glycaemic targets and therapeutic choices should be modified by routinely assessing frailty. Know more about the details of such recommendation and treatment simplification, switching, or de-escalation in older population through this video.

Advancing Therapy with iGlarLixi: Differentiation from complex insulin regimens

An educational video outlining key data from indirect comparisons of iGlarLixi versus IDegAsp.

Read article

Advancing Therapy with iGlarLixi: Differentiation from other complex regimens

Read article

Treatment simplification of complex insulin regimens in T2D

An educational video to discuss the challenges associated with commonly-used insulin advancement options and the need for treatment simplification for many adults with T2D. The video reviews data supporting the use of BI + GLP-1 RA FRCs versus commonly-used insulin regimens in adults with T2D.

Read article

MAT-BH-2400490/v1/Aug 2024